Medical Condition News

RSS

Care lags for people who have stroke in hospital, study finds

At the first sign of a stroke, time is of the essence. For every minute of delay in treatment, people typically lose almost two million brain cells. Yet a new study presented at the Canadian Stroke Congress reveals that those delays - in getting the right tests and the right drugs - can be longer when people experience a stroke in a hospital.

6 Oct 2014

'Win-win' program provides better care to stroke patients, reduces hospital bed days

An innovative patient management system at the acute stroke unit of Kelowna (BC) General Hospital has reduced the number of stroke patient bed days by more than 25 per cent, according to a study of the system presented at the annual Canadian Stroke Congress in Vancouver.

6 Oct 2014

Researchers discover rare disease that affects heart rate, intestinal movements

Physicians and researchers at CHU Sainte-Justine, Universit- de Montr-al, CHU de Qu-bec, Universit- Laval, and Hubrecht Institute have discovered a rare disease affecting both heart rate and intestinal movements.

6 Oct 2014

Modified form of niclosamide drug may hold key to battling type 2 diabetes

Type 2 diabetes affects an estimated 28 million Americans according to the American Diabetes Association, but medications now available only treat symptoms, not the root cause of the disease.

6 Oct 2014

Researchers find potential new way to better control immune-mediated diseases

Researchers at University of California, San Diego School of Medicine have discovered that T-cells - a type of white blood cell that learns to recognize and attack microbial pathogens - are activated by a pain receptor.

6 Oct 2014

New study suggests that family meals may be protective against obesity

Increasing rates of adolescent obesity and the likelihood that obesity will carry forward into adulthood, have led to various preventive initiatives. It has been suggested that family meals, which tend to include fruits, vegetables, calcium, and whole grains, could be protective against obesity.

5 Oct 2014

CTRC researcher receives special $1.62 million orphan disease grant from FDA

A researcher at the Cancer Therapy & Research Center is the leader on a study receiving a special $1.62 million orphan disease grant from the Food & Drug Administration.

5 Oct 2014

Damage to right frontal-subcortical network may cause ipsilateral spatial neglect

Stroke researchers have confirmed that damage to the right frontal-subcortical network may cause ipsilateral spatial neglect. Among individuals with ipsilateral neglect, a much greater proportion had frontal subcortical damage than anticipated by the investigators - 83% vs the expected 27%.

5 Oct 2014

Kessler Foundation, NJHF partner to advance biomedical research

The signing of a formal affiliation agreement that allows Kessler Foundation and New Jersey Health Foundation to work together to advance biomedical research, education and patient care programs has been announced by Rodger DeRose, president and chief executive officer of Kessler Foundation and James M. Golubieski, president of New Jersey Health Foundation.

5 Oct 2014

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

Eli Lilly and Company announced today it will discontinue development of tabalumab -- being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) -- due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.

3 Oct 2014

TxCell to highlight development, progress of ASTrIA platform at 13th Annual BIO Investor Forum

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today Damian Marron, CEO, TxCell will be presenting at the 13th Annual BIO Investor Forum, October 7-8, 2014 at the Palace Hotel in San Francisco, California, US.

3 Oct 2014

Leading experts urge Canadian health-care providers to improve care for people living with SCI

Leading Canadian spinal cord injury (SCI) experts have launched the unprecedented Spinal Cord Injury: A Manifesto for Change—a call to action and a plea for Canadian health-care providers and stakeholders to work in coordination to improve care and the health of people living with SCI in Canada.

3 Oct 2014

CytoSorbents announces launch of International CytoSorb Treatment Registry

CytoSorbents Corporation, a critical care immunotherapy company using blood purification to treat life-threatening conditions, announced the launch of its International CytoSorb Treatment Registry, established and managed by the Center of Clinical Trials at the University of Jena, Germany.

3 Oct 2014

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

Halozyme Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for PEGylated recombinant human hyaluronidase (PEGPH20) for the treatment of pancreatic cancer.

3 Oct 2014

TyrRS enzyme protects DNA during cellular stress

Scientists at The Scripps Research Institute have found that an enzyme best known for its fundamental role in building proteins has a second major function: to protect DNA during times of cellular stress.

3 Oct 2014

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Surveying patients with traumatic brain injuries, a group of Los Angeles Biomedical Research Institute researchers reported today that they found those who tested positive for THC, the active ingredient in marijuana, were more likely to survive than those who tested negative for the illicit substance.

3 Oct 2014

Energy drinks increase frequency of insomnia, nervousness in athletes

A study analysing the positive and negative effects of energy drinks on athletes has seen that, although in principle their sports performance was seen to improve by between 3% and 7%, there was also an increase in the frequency of insomnia, nervousness and the level of stimulation in the hours following competition.

3 Oct 2014

Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

Diet-induced changes in the gut's bacterial ecosystem can alter susceptibility to an autoinflammatory bone disease by modifying the immune response, St. Jude Children's Research Hospital scientists reported. The findings appeared September 28 as an advanced online publication of the scientific journal Nature.

3 Oct 2014

Montmorency cherry concentrate helps reduce effects of gout

Drinking Montmorency concentrate significantly helps to reduce the effects of the painful condition gout, according to new research.

3 Oct 2014

Benefits of low-carbohydrate diet for patients with type 2 diabetes

Low-carbohydrate diet has a good effect not only on blood glucose, but also on physical functions, bodily pain and general health, according to a diet study including patients with type 2 diabetes.

3 Oct 2014

Medical Condition News

Care lags for people who have stroke in hospital, study finds

'Win-win' program provides better care to stroke patients, reduces hospital bed days

Researchers discover rare disease that affects heart rate, intestinal movements

Modified form of niclosamide drug may hold key to battling type 2 diabetes

Researchers find potential new way to better control immune-mediated diseases

New study suggests that family meals may be protective against obesity

CTRC researcher receives special $1.62 million orphan disease grant from FDA

Damage to right frontal-subcortical network may cause ipsilateral spatial neglect

Kessler Foundation, NJHF partner to advance biomedical research

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

TxCell to highlight development, progress of ASTrIA platform at 13th Annual BIO Investor Forum

Leading experts urge Canadian health-care providers to improve care for people living with SCI

CytoSorbents announces launch of International CytoSorb Treatment Registry

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

TyrRS enzyme protects DNA during cellular stress

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Energy drinks increase frequency of insomnia, nervousness in athletes

Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

Montmorency cherry concentrate helps reduce effects of gout

Benefits of low-carbohydrate diet for patients with type 2 diabetes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News